GlassScriptPhysician profile
Thomas Griffin Gaines
NPI 1679731574
$3,294.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $1,993 · 2021: $41.24 · 2022: $18.36 · 2023: $82.30 · 2024: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,254.85 | 2019-2020 | |
| Abiomed | $392.12 | 2019-2020 | |
| Amgen INC. | $332.66 | 2019-2020 | |
| Cardiovascular Systems INC. | $274.32 | 2019-2021 | |
| Edwards Lifesciences Corporation | $169.78 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $124.17 | 2019-2022 | |
| Chiesi USA, INC. | $109.78 | 2019 | |
| Pfizer INC. | $104.34 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $93.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $91.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $81.19 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $43.84 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.65 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $33.14 | 2023 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $31.47 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $28.38 | 2019 | |
| Bard Peripheral Vascular, INC. | $23.85 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.50 | 2019 | |
| Cardinal Health 200 LLC | $16.25 | 2019 | |
| Terumo Medical Corporation | $16.17 | 2020 | |
| Irhythm Technologies, INC. | $15.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gaines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.